Skip to main content

Cohen Lawrence B

SEC CIK
0001324022
Latest filing
Feb 9, 2024

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Cohen Lawrence B, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q4 2023 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
10
Since Q2 2021
Holdings of ALNY by Cohen Lawrence B, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−1,800−100.0%Sold outHolders
Q3 20231,800$318.8K0.2%00.0%UnchangedHolders
Q2 20231,800$341.9K0.2%00.0%UnchangedHolders
Q1 20231,800$360.6K0.2%00.0%UnchangedHolders
Q4 20221,800$427.8K0.2%00.0%UnchangedHolders
Q3 20221,800$360.0K0.3%00.0%UnchangedHolders
Q2 20221,800$263.0K0.2%00.0%UnchangedHolders
Q1 20221,800$294.0K0.2%00.0%UnchangedHolders
Q4 20211,800$305.0K0.1%00.0%UnchangedHolders
Q3 20211,800$340.0K0.2%00.0%UnchangedHolders
Q2 20211,800$305.0K0.2%+1,800NewHolders